Valuation for Heidelberg Pharma AG (id:2810 HPHA)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | -4.95 |
|
|
| Forward P/E | -5.30 |
|
|
| Price to sales | 13.42 |
|
|
| Price to book | 3.05 |
|
|
| Enterprise to revenue | 8.60 |
|
|
| Enterprise to ebitda | -3.45 |
|
|